Comparison

Anti-Telomerase Associated Protein 1 (TEP1)

Item no. 18-732-292583
Manufacturer GENWAY
Amount 0.1 mg
Category
Type Proteins
Applications WB, IP, ELISA
Specific against other
ECLASS 10.1 32160409
ECLASS 11.0 32160409
UNSPSC 12352202
Alias GWB-275867
Similar products 18-732-292583
Available
Genway ID:
GWB-275867
Antigen:
Telomerase Associated Protein 1 (TEP1)
Immunogen:
This affinity purified antibody was prepared from whole rabbit serum produced by repeated immunizations with a synthetic peptide corresponding to a region near the amino terminus of human telomerase associated protein 1 (TEP1). Family: Transcription Factor Fraction: Affinity Purified
Application Note:
This affinity purified antibody has beentested for use in ELISA and western blotting. Specificconditions for reactivity should be optimized by the end user. Expect a band at ~240 kDa in size corresponding to TEP1 bywestern blotting in the appropriate cell lysate or extract. Human kidney tissue lysate can be used as positive control. Recommended
Dilution:
ELISA 1:10 000 - 1:40 000WESTERN BLOT 1 -2 ?g/mlIF MICROSCOPY User OptimizedOTHER APPLICATIONS User OptimizedPhysical State: Liquid (sterile filtered)Purity and
Specificity:
This affinity purified antibody is directed against human TEP1 protein. The product was affinity purified from monospecific antiserum by immunoaffinity chromatography. A BLAST analysis was used to suggest that this antibody would react with TEP1 from human mouse and rat sources. Antibody
Concentration:
1. 0 mg/ml (by UV absorbance at 280 nm)
Stabilizer:
None
Ship Code:
Dry Ice Telomerase is an RNA-dependent DNApolymerase that uses an RNA component to add telomericrepeat sequences at the ends of chromosomes. Besides theRNA component which serves as the template that specifiesthe telomeric repeat the telomerase complex contains areverse transcriptase protein (TRT) and various accessoryproteins including the telomerase-associated protein 1(TP1). Telomerase activity is low in most somatic cells causing the gradual shortening of telomeres which canultimately lead to telomere fusion and cell death. High levelsof telomerase activity are widely seen in cancerous cells andwhile recent experiments have suggested that telomerasemay be a viable target in cancer therapy expression levelsof TP1 do not correlate with malignancy. At least twoisoforms of TP1 are known to exist. Greider CW. Telomere length regulation. Annu. Rev. Biochem. 1996; 274:92-7. Cong YS Wright WE and Shay JW. Human telomerase and its regulation. Microbiol. Mol. Biol. Rev. 2002; 66:407-25. Harrington L McPhail T Mar V et al. A mammalian telomerase-associated protein. Science 1997; 275:973-7. Wong JMY and Collins K. Telomere maintenance and disease. Lancet 2003; 362:983-8. Cunningham AP Love WK Zhang RW et al. Telomerase inhibition in cancer therapeutics: molecular-based approaches. Curr. Med. Chem. 2006; 13:2875-88. Hu S Chan HL Chen MC et al. Telomerase expression in benign and malignant skin neoplasms: comparison of three major subunits. J. Formos. Med. Assoc. 2002; 101:593-7.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.1 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close